Manabu Kawamoto
Overview
Explore the profile of Manabu Kawamoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takagi K, Kawamoto M, Higuchi T, Tochimoto A, Hirose H, Harigai M, et al.
Int J Rheum Dis
. 2021 Apr;
24(6):803-808.
PMID: 33909342
Aim: Calcinosis is often observed in systemic sclerosis (SSc), but its pathogenesis remains unclear. The aim of the present study was to explore the association of clinical features with calcinosis...
2.
Igarashi K, Hori T, Yamamoto M, Hatakeyama N, Iesato K, Takebayashi A, et al.
J Pediatr Hematol Oncol
. 2021 Feb;
43(8):e1136-e1139.
PMID: 33560083
Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disorder accompanied by periodic fever and sterile serositis. We report a 5-year-old boy with FMF, who underwent second unrelated cord blood transplantation...
3.
Takagi K, Kawamoto M, Higuchi T, Tochimoto A, Harigai M, Kawaguchi Y
Int J Rheum Dis
. 2020 Mar;
23(5):674-680.
PMID: 32144871
Aim: Hypoxia-inducible factor (HIF)1α is induced by endothelial cells under hypoxic conditions, suggesting that HIF1α may be involved in vascular impairment in patients with systemic sclerosis (SSc). The purpose of...
4.
Miyamae T, Hanaya A, Kawamoto M, Tani Y, Kawaguchi Y, Yamanaka H
J Clin Rheumatol
. 2020 Feb;
26(2):60-62.
PMID: 32073516
Objectives: This is a noncomparative study performed to determine if fever pattern is related to a diagnosis of autoinflammatory disease (AID) in pediatric- and adult-onset patients. Methods: The final diagnosis...
5.
Katsumata Y, Okamoto Y, Moriyama T, Moriyama R, Kawamoto M, Hanaoka M, et al.
Immunol Med
. 2020 Jan;
43(1):47-56.
PMID: 31910103
Associations between anti-M-type phospholipase A2 receptor (PLA2R) antibodies and disease activity and prognosis have been suggested in primary membranous nephropathy (MN); however, more evidence is needed. We aimed to establish...
6.
Tani Y, Kishi T, Miyamae T, Kawamoto M, Kawaguchi Y, Taniguchi A, et al.
Clin Rheumatol
. 2020 Jan;
39(3):841-845.
PMID: 31897954
Objectives: Palindromic rheumatism (PR) is a type of acute arthritis or periarthritis characterized by recurrence, paroxysmal, or intermittent disease attacks and occasionally progresses to other types of rheumatic disease. PR...
7.
IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand
Yago T, Nanke Y, Kawamoto M, Kobashigawa T, Yamanaka H, Kotake S
Cent Eur J Immunol
. 2018 Aug;
43(2):148-154.
PMID: 30135626
IL-35 is known as a regulatory cytokine produced by regulatory T cells. It has also been reported that IL-35 suppresses the proliferation of Th17 cells, which is involved in the...
8.
Shimura K, Miura J, Kawamoto M, Kawaguchi Y, Yamanaka H, Uchigata Y
Diabetes Metab Res Rev
. 2018 May;
34(7):e3023.
PMID: 29762907
Background: Clusters of autoimmune diseases (ADs) are present in some people with type 1 diabetes. This clustering suggests the existence of common genetic backgrounds for abnormal autoimmunity in these individuals....
9.
Yago T, Nanke Y, Kawamoto M, Kobashigawa T, Yamanaka H, Kotake S
J Clin Med
. 2017 Aug;
6(9).
PMID: 28850053
IL-23, which is composed of p19 and p40 subunits, is a proinflammatory cytokine that contributes to the formation and maintenance of Th17 cells in inflammatory autoimmune diseases. IL-23 is a...
10.
Nanke Y, Kobashigawa T, Yago T, Kawamoto M, Yamanaka H, Kotake S
Biomed Res Int
. 2016 Dec;
2016:6824719.
PMID: 27965978
. Drug repositioning or drug reprofiling (DR) has recently been growing in importance. DR has a significant advantage over traditional drug development because the repositioned drug has already passed toxicity...